Planet 13 Holdings (PLNH) Net Cash Flow Growth (3y) (2024 - 2026)
Planet 13 Holdings (PLNH) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | -62.71% |
| 10 | Planet 13 Holdings | 37.38 Mn | 21.13 Mn | 9.41 Mn | 27.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.19% |
| Dec 31, 2025 | 6.80% |
| Sep 30, 2025 | 39.84% |
| Jun 30, 2025 | 50.45% |
| Mar 31, 2025 | -70.21% |
| Dec 31, 2024 | 61.45% |
| Sep 30, 2024 | 28.10% |
| Jun 30, 2024 | 48.45% |
| Mar 31, 2024 | -55.19% |